These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 35637197)
1. The Achilles' heel of cancer: targeting tumors via lysosome-induced immunogenic cell death. Iulianna T; Kuldeep N; Eric F Cell Death Dis; 2022 May; 13(5):509. PubMed ID: 35637197 [TBL] [Abstract][Full Text] [Related]
2. Targeted Enrichment of Enzyme-Instructed Assemblies in Cancer Cell Lysosomes Turns Immunologically Cold Tumors Hot. Ji S; Li J; Duan X; Zhang J; Zhang Y; Song M; Li S; Chen H; Ding D Angew Chem Int Ed Engl; 2021 Dec; 60(52):26994-27004. PubMed ID: 34643312 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system. Calvillo-Rodríguez KM; Lorenzo-Anota HY; Rodríguez-Padilla C; Martínez-Torres AC; Scott-Algara D Front Immunol; 2023; 14():1294434. PubMed ID: 38077402 [TBL] [Abstract][Full Text] [Related]
4. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy. Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A Cells; 2021 Jan; 10(2):. PubMed ID: 33504012 [TBL] [Abstract][Full Text] [Related]
6. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives. Aria H; Rezaei M Biomed Pharmacother; 2023 May; 161():114503. PubMed ID: 36921539 [TBL] [Abstract][Full Text] [Related]
7. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy. Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933 [TBL] [Abstract][Full Text] [Related]
8. Microbes mediated immunogenic cell death in cancer immunotherapy. Huang J; Duan F; Xie C; Xu J; Zhang Y; Wang Y; Tang YP; Leung EL Immunol Rev; 2024 Jan; 321(1):128-142. PubMed ID: 37553793 [TBL] [Abstract][Full Text] [Related]
9. Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer. Ma J; Ramachandran M; Jin C; Quijano-Rubio C; Martikainen M; Yu D; Essand M Cell Death Dis; 2020 Jan; 11(1):48. PubMed ID: 31969562 [TBL] [Abstract][Full Text] [Related]
11. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Meier P; Legrand AJ; Adam D; Silke J Nat Rev Cancer; 2024 May; 24(5):299-315. PubMed ID: 38454135 [TBL] [Abstract][Full Text] [Related]
12. Necroptosis in Immuno-Oncology and Cancer Immunotherapy. Sprooten J; De Wijngaert P; Vanmeerbeerk I; Martin S; Vangheluwe P; Schlenner S; Krysko DV; Parys JB; Bultynck G; Vandenabeele P; Garg AD Cells; 2020 Aug; 9(8):. PubMed ID: 32752206 [TBL] [Abstract][Full Text] [Related]
13. Peptide-Driven Proton Sponge Nano-Assembly for Imaging and Triggering Lysosome-Regulated Immunogenic Cancer Cell Death. He T; Wen J; Wang W; Hu Z; Ling C; Zhao Z; Cheng Y; Chang YC; Xu M; Jin Z; Amer L; Sasi L; Fu L; Steinmetz NF; Rana TM; Wu P; Jokerst JV Adv Mater; 2024 May; 36(19):e2307679. PubMed ID: 38372431 [TBL] [Abstract][Full Text] [Related]
14. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy. Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476 [TBL] [Abstract][Full Text] [Related]
15. Radiation-Induced Immunogenic Cell Death for Cancer Radioimmunotherapy. Liu T; Pei P; Shen W; Hu L; Yang K Small Methods; 2023 May; 7(5):e2201401. PubMed ID: 36811166 [TBL] [Abstract][Full Text] [Related]
16. Polymeric Nanosystems for Immunogenic Cell Death-Based Cancer Immunotherapy. Fu L; Zhou X; He C Macromol Biosci; 2021 Jul; 21(7):e2100075. PubMed ID: 33885225 [TBL] [Abstract][Full Text] [Related]
17. Activating Nanomedicines with Electromagnetic Energy for Deep-Tissue Induction of Immunogenic Cell Death in Cancer Immunotherapy. Wang F; Pu K; Li J Small Methods; 2023 May; 7(5):e2201083. PubMed ID: 36316270 [TBL] [Abstract][Full Text] [Related]
18. Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle. Tu L; Li C; Ding Q; Sharma A; Li M; Li J; Kim JS; Sun Y J Am Chem Soc; 2024 Apr; 146(13):8991-9003. PubMed ID: 38513217 [TBL] [Abstract][Full Text] [Related]
19. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells. Solari JIG; Filippi-Chiela E; Pilar ES; Nunes V; Gonzalez EA; Figueiró F; Andrade CF; Klamt F BMC Cancer; 2020 May; 20(1):474. PubMed ID: 32456685 [TBL] [Abstract][Full Text] [Related]